AeroShot “Inhalable Caffeine” Linked to Binge Drinking and Other Health Risks

Breathable caffeine dispensed from canisters that fit in pants pockets is a ‘club drug’ that may be dangerous to youth, according to New York Senator Charles Schumer. The senator wrote Food and Drug Administration Commissioner Margaret Hamburg asking her to review the safety and legality of the AeroShot Pure Energy caffeine inhaler, a yellow and gray canister of caffeine powder and B vitamins resembling a tube of lipstick. The inhaler is set to hit store shelves in New York and Boston next month.

AeroShot will be sold over the counter with no age restrictions and is touted for its convenience and zero calories. If taken with alcohol, the mixture may have effects similar to caffeinated alcohol drinks tied to hospitalizations in the past, Schumer said. Doctors say it may carry neurological and cardiovascular risks.

“The product is nothing more than a club drug designed to give users the ability to drink until they drop,” Schumer told The Washington Post.

The inhaler is sold online by Cambridge, Massachusetts-based Breathable Foods Inc. and The Lab Store, in Paris. AeroShot advertising in Europe focuses on drinking and partying, Schumer said in a statement, adding that he’s concerned it could be a health hazard to teens. The inhaler was created by David Edwards, a professor at Harvard University’s School of Engineering and Applied Sciences, who also invented Le Whif, a calorie-free inhalable chocolate.

AeroShot delivers 100 milligrams of caffeine, the same amount in a large cup of coffee. The caffeine is absorbed in the mouth and digestive tract, not through the lungs, according to a fact sheet from Breathable Foods. AeroShot is priced at $2.99 and is not intended for anyone younger than 12, according to the product’s website.

The company’s claims are unsubstantiated, Schumer said, noting the American Academy of Pediatrics discourages the non- medical use of caffeine by children and adolescents. The Elk Grove Village, Illinois-based doctor’s group wrote AeroShot’s manufacturer about concerns over caffeine’s effect on developing neurologic and cardiovascular systems and the potential for the product to exacerbate asthma. Their letter also raises concerns about the potential for the use of this product with alcohol, especially in light of the manner in which it is marketed.